Search results
Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know
Zacks via Yahoo Finance· 5 days agoThese revisions help to show the ever-changing nature of near-term business trends. Hence, positive...
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
Zacks· 4 days agoFree Report) has been one of the most searched-for stocks on Zacks.com lately. Over the past month, shares of this biopharmaceutical company have returned -4.8%, compared ...
Bristol-Myers Squibb (NYSE:BMY) Stock Price Down 0.6%
ETF DAILY NEWS· 14 hours agoBristol-Myers Squibb (NYSE:BMY – Get Free Report)’s share price traded down 0.6% during trading on Friday . The stock traded as low as ...
V Square Quantitative Management LLC Has $1.75 Million Stake in Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 12 hours agoV Square Quantitative Management LLC grew its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 100.0% in the 4th quarter, according ...
Able Wealth Management LLC Acquires New Position in Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 1 day agoAble Wealth Management LLC purchased a new stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) in the 4th quarter, Holdings Channel.com reports. The ...
Bristol-Myers Squibb (NYSE:BMY) Shares Down 2.6%
ETF DAILY NEWS· 1 day agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) shares fell 2.6% during mid-day trading on Thursday . The stock traded as low as $41.30 ...
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
Motley Fool via Yahoo Finance· 20 hours agoShares of Pfizer (NYSE: PFE), Bristol Myers Squibb (NYSE: BMY), and CVS Health (NYSE: CVS) are down,...
Why Bristol Myers Squibb Is A Top Socially Responsible Dividend Stock
Forbes· 7 days agoBristol Myers Squibb has been named a Top Socially Responsible Dividend Stock
Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb
Digital Journal· 4 days ago...ACCESSWIRE / June 12, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) announced today that the Company has reached important scientific progress within its neuroscience collaboration with Bristol Myers Squibb (NYSE:BMY) triggering a research payment...
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
Zacks via Yahoo Finance· 2 days agoThe FDA approves Bristol Myers' (BMY) cancer drug Augtyro for the treatment of adult and pediatric...